Bicycle Therapeutics (BCYC)
(Delayed Data from NSDQ)
$22.89 USD
-0.69 (-2.93%)
Updated May 10, 2024 04:00 PM ET
After-Market: $22.88 -0.01 (-0.04%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-1.10 | 0.00% |
Earnings Summary
For their last quarter, Bicycle Therapeutics (BCYC) reported earnings of -$0.62 per share, beating the Zacks Consensus Estimate of $-1.26 per share. This reflects a positive earnings surprise of 50.79%. Look out for BCYC's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$1.10 per share, reflecting a year-over-year increase of 21.99%.
Earnings History
Price & Consensus
Zacks News for BCYC
Wall Street Analysts See a 77.22% Upside in Bicycle Therapeutics (BCYC): Can the Stock Really Move This High?
BCYC: What are Zacks experts saying now?
Zacks Private Portfolio Services